Global Hemoglobin A1c Monitoring Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 104

Report ID: 4039

An A1C test is a blood test that reflects your average blood glucose levels over the past 3 months. The A1C test is sometimes called the hemoglobin A1C, HbA1c, glycated hemoglobin, or glycohemoglobin test. Hemoglobin is the part of a red blood cell that carries oxygen to the cells.
Determining glycated hemoglobin levels assure healthcare professionals about the patient’s blood glucose levels. This test is used for diagnosing and monitoring hemoglobin A1c levels in the diabetic patients. As the A1c test reflects the average amount of glucose for the past two to three months, it is considered to be more reliable than traditional blood glucose tests. Due to increasing incidence of diabetes and growing awareness of better management of diabetes, the global hemoglobin A1c testing devices market is expected to develop rapidly in the years to come. Nowadays, medical professionals usually prescribe HbA1c test over conventional blood glucose tests to patients.
In 2018, the global Hemoglobin A1c Monitoring market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Hemoglobin A1c Monitoring status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hemoglobin A1c Monitoring development in United States, Europe and China.

The key players covered in this study
Bayer Healthcare Diabetes Care (US)
Abbott Laboratories (US)
Roche Diagnostics (Switzerland)
Axis-Shield plc (UK)
Beckman Coulter, Inc. (US)
Bio-Rad Laboratories Inc (US)
Diazyme Laboratories Inc. (US)
EKF Diagnostics Holdings Plc (UK)
HEMOCUE(r) AB (Sweden)
Infopia Co. Ltd. (South Korea)
Menarini Diagnostics Ltd. (UK)
Siemens Healthcare Diagnostics (Germany)
Tosoh Bioscience, Inc (US)
Trinity Biotech plc (Ireland)
ARKRAY, Inc. (Japan)

Market segment by Type, the product can be split into
Ion-exchange
High-performance liquid chromatography (HPLC)
Immunoassay
Boronate affinity chromatography
Direct enzymatic assay

Market segment by Application, split into
HbA1c Laboratory Testing
HbA1c Point of Care Testing

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Hemoglobin A1c Monitoring status, future forecast, growth opportunity, key market and key players.
To present the Hemoglobin A1c Monitoring development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hemoglobin A1c Monitoring are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hemoglobin A1c Monitoring Market Size Growth Rate by Type (2014-2025)
1.4.2 Ion-exchange
1.4.3 High-performance liquid chromatography (HPLC)
1.4.4 Immunoassay
1.4.5 Boronate affinity chromatography
1.4.6 Direct enzymatic assay
1.5 Market by Application
1.5.1 Global Hemoglobin A1c Monitoring Market Share by Application (2014-2025)
1.5.2 HbA1c Laboratory Testing
1.5.3 HbA1c Point of Care Testing
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Hemoglobin A1c Monitoring Market Size
2.2 Hemoglobin A1c Monitoring Growth Trends by Regions
2.2.1 Hemoglobin A1c Monitoring Market Size by Regions (2014-2025)
2.2.2 Hemoglobin A1c Monitoring Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Hemoglobin A1c Monitoring Market Size by Manufacturers
3.1.1 Global Hemoglobin A1c Monitoring Revenue by Manufacturers (2014-2019)
3.1.2 Global Hemoglobin A1c Monitoring Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hemoglobin A1c Monitoring Market Concentration Ratio (CR5 and HHI)
3.2 Hemoglobin A1c Monitoring Key Players Head office and Area Served
3.3 Key Players Hemoglobin A1c Monitoring Product/Solution/Service
3.4 Date of Enter into Hemoglobin A1c Monitoring Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Hemoglobin A1c Monitoring Market Size by Type (2014-2019)
4.2 Global Hemoglobin A1c Monitoring Market Size by Application (2014-2019)

5 United States
5.1 United States Hemoglobin A1c Monitoring Market Size (2014-2019)
5.2 Hemoglobin A1c Monitoring Key Players in United States
5.3 United States Hemoglobin A1c Monitoring Market Size by Type
5.4 United States Hemoglobin A1c Monitoring Market Size by Application

6 Europe
6.1 Europe Hemoglobin A1c Monitoring Market Size (2014-2019)
6.2 Hemoglobin A1c Monitoring Key Players in Europe
6.3 Europe Hemoglobin A1c Monitoring Market Size by Type
6.4 Europe Hemoglobin A1c Monitoring Market Size by Application

7 China
7.1 China Hemoglobin A1c Monitoring Market Size (2014-2019)
7.2 Hemoglobin A1c Monitoring Key Players in China
7.3 China Hemoglobin A1c Monitoring Market Size by Type
7.4 China Hemoglobin A1c Monitoring Market Size by Application

8 Japan
8.1 Japan Hemoglobin A1c Monitoring Market Size (2014-2019)
8.2 Hemoglobin A1c Monitoring Key Players in Japan
8.3 Japan Hemoglobin A1c Monitoring Market Size by Type
8.4 Japan Hemoglobin A1c Monitoring Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Hemoglobin A1c Monitoring Market Size (2014-2019)
9.2 Hemoglobin A1c Monitoring Key Players in Southeast Asia
9.3 Southeast Asia Hemoglobin A1c Monitoring Market Size by Type
9.4 Southeast Asia Hemoglobin A1c Monitoring Market Size by Application

10 India
10.1 India Hemoglobin A1c Monitoring Market Size (2014-2019)
10.2 Hemoglobin A1c Monitoring Key Players in India
10.3 India Hemoglobin A1c Monitoring Market Size by Type
10.4 India Hemoglobin A1c Monitoring Market Size by Application

11 Central & South America
11.1 Central & South America Hemoglobin A1c Monitoring Market Size (2014-2019)
11.2 Hemoglobin A1c Monitoring Key Players in Central & South America
11.3 Central & South America Hemoglobin A1c Monitoring Market Size by Type
11.4 Central & South America Hemoglobin A1c Monitoring Market Size by Application

12 International Players Profiles
12.1 Bayer Healthcare Diabetes Care (US)
12.1.1 Bayer Healthcare Diabetes Care (US) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hemoglobin A1c Monitoring Introduction
12.1.4 Bayer Healthcare Diabetes Care (US) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
12.1.5 Bayer Healthcare Diabetes Care (US) Recent Development
12.2 Abbott Laboratories (US)
12.2.1 Abbott Laboratories (US) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hemoglobin A1c Monitoring Introduction
12.2.4 Abbott Laboratories (US) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
12.2.5 Abbott Laboratories (US) Recent Development
12.3 Roche Diagnostics (Switzerland)
12.3.1 Roche Diagnostics (Switzerland) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hemoglobin A1c Monitoring Introduction
12.3.4 Roche Diagnostics (Switzerland) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
12.3.5 Roche Diagnostics (Switzerland) Recent Development
12.4 Axis-Shield plc (UK)
12.4.1 Axis-Shield plc (UK) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hemoglobin A1c Monitoring Introduction
12.4.4 Axis-Shield plc (UK) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
12.4.5 Axis-Shield plc (UK) Recent Development
12.5 Beckman Coulter, Inc. (US)
12.5.1 Beckman Coulter, Inc. (US) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hemoglobin A1c Monitoring Introduction
12.5.4 Beckman Coulter, Inc. (US) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
12.5.5 Beckman Coulter, Inc. (US) Recent Development
12.6 Bio-Rad Laboratories Inc (US)
12.6.1 Bio-Rad Laboratories Inc (US) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hemoglobin A1c Monitoring Introduction
12.6.4 Bio-Rad Laboratories Inc (US) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
12.6.5 Bio-Rad Laboratories Inc (US) Recent Development
12.7 Diazyme Laboratories Inc. (US)
12.7.1 Diazyme Laboratories Inc. (US) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hemoglobin A1c Monitoring Introduction
12.7.4 Diazyme Laboratories Inc. (US) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
12.7.5 Diazyme Laboratories Inc. (US) Recent Development
12.8 EKF Diagnostics Holdings Plc (UK)
12.8.1 EKF Diagnostics Holdings Plc (UK) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hemoglobin A1c Monitoring Introduction
12.8.4 EKF Diagnostics Holdings Plc (UK) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
12.8.5 EKF Diagnostics Holdings Plc (UK) Recent Development
12.9 HEMOCUE(r) AB (Sweden)
12.9.1 HEMOCUE(r) AB (Sweden) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hemoglobin A1c Monitoring Introduction
12.9.4 HEMOCUE(r) AB (Sweden) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
12.9.5 HEMOCUE(r) AB (Sweden) Recent Development
12.10 Infopia Co. Ltd. (South Korea)
12.10.1 Infopia Co. Ltd. (South Korea) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Hemoglobin A1c Monitoring Introduction
12.10.4 Infopia Co. Ltd. (South Korea) Revenue in Hemoglobin A1c Monitoring Business (2014-2019)
12.10.5 Infopia Co. Ltd. (South Korea) Recent Development
12.11 Menarini Diagnostics Ltd. (UK)
12.12 Siemens Healthcare Diagnostics (Germany)
12.13 Tosoh Bioscience, Inc (US)
12.14 Trinity Biotech plc (Ireland)
12.15 ARKRAY, Inc. (Japan)

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details